387 related articles for article (PubMed ID: 16343039)
1. Folate co-administration improves the effectiveness of fenofibrate to decrease the lipoprotein oxidation and endothelial dysfunction surrogates.
Mayer O; Simon J; Holubec L; Pikner R; Trefil L
Physiol Res; 2006; 55(5):475-481. PubMed ID: 16343039
[TBL] [Abstract][Full Text] [Related]
2. Fenofibrate-induced hyperhomocysteinemia may be prevented by folate co-administration.
Mayer O; Simon J; Holubec L; Pikner R; Subrt I
Eur J Clin Pharmacol; 2003 Sep; 59(5-6):367-71. PubMed ID: 12845504
[TBL] [Abstract][Full Text] [Related]
3. Effect of combined fluvastatin-fenofibrate therapy compared with fenofibrate monotherapy in severe primary hypercholesterolemia. French Fluvastatin Study Group.
Farnier M; Dejager S
Am J Cardiol; 2000 Jan; 85(1):53-7. PubMed ID: 11078237
[TBL] [Abstract][Full Text] [Related]
4. Effects of baseline level of triglycerides on changes in lipid levels from combined fluvastatin + fibrate (bezafibrate, fenofibrate, or gemfibrozil).
Farnier M; Salko T; Isaacsohn JL; Troendle AJ; Dejager S; Gonasun L
Am J Cardiol; 2003 Oct; 92(7):794-7. PubMed ID: 14516878
[TBL] [Abstract][Full Text] [Related]
5. [Long-term treatment of combined hyperlipidemia with a combination of fluvastatin and fenofibrate].
Widimský J; Hulínský V; Balazovjech I; Lánská V
Vnitr Lek; 1999 Apr; 45(4):210-6. PubMed ID: 11045181
[TBL] [Abstract][Full Text] [Related]
6. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy with fluvastatin as monotherapy and combined with cholestyramine (a 156-week multicenter study). French-Dutch Fluvastatin Study Group.
Jacotot B; Banga JD; Waite R; Peters TK
Am J Cardiol; 1995 Jul; 76(2):41A-46A. PubMed ID: 7604796
[TBL] [Abstract][Full Text] [Related]
8. Fenofibrate improves the atherogenic lipid profile and enhances LDL resistance to oxidation in HIV-positive adults.
Badiou S; Merle De Boever C; Dupuy AM; Baillat V; Cristol JP; Reynes J
Atherosclerosis; 2004 Feb; 172(2):273-9. PubMed ID: 15019537
[TBL] [Abstract][Full Text] [Related]
9. [Antilipemic agents in combined therapy].
Márk L; Császár A
Orv Hetil; 2002 Aug; 143(34):1973-8. PubMed ID: 12422650
[TBL] [Abstract][Full Text] [Related]
10. Combined treatment of hypercholesterolemia of renal transplant allograft recipients with fluvastatin and gemfibrozil.
Vergoulas G; Miserlis G; Solonaki F; Imvrios G; Gakis D; Papanikolaou V; Papagiannis A; Visvardis G; Takoudas D; Antoniadis A
Transpl Int; 2000; 13 Suppl 1():S64-7. PubMed ID: 11111964
[TBL] [Abstract][Full Text] [Related]
11. The effect of B-vitamins on hyperhomocysteinemia in patients on antiepileptic drugs.
Apeland T; Mansoor MA; Pentieva K; McNulty H; Seljeflot I; Strandjord RE
Epilepsy Res; 2002 Oct; 51(3):237-47. PubMed ID: 12399074
[TBL] [Abstract][Full Text] [Related]
12. [Combination therapy with fluvastatin and fenofibrate in ischemic heart disease patients with combined hyperlipidemia and type 2 diabetes].
Sarano NE; Kozlov SG; Tvorogova MG; Liakishev AA; Naumov VG
Kardiologiia; 2003; 43(4):30-5. PubMed ID: 12891248
[TBL] [Abstract][Full Text] [Related]
13. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia.
Broyles FE; Walden CE; Hunninghake DB; Hill-Williams D; Knopp RH
Am J Cardiol; 1995 Jul; 76(2):129A-135A. PubMed ID: 7604788
[TBL] [Abstract][Full Text] [Related]
14. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
[TBL] [Abstract][Full Text] [Related]
15. Fluvastatin with and without niacin for hypercholesterolemia.
Jacobson TA; Chin MM; Fromell GJ; Jokubaitis LA; Amorosa LF
Am J Cardiol; 1994 Jul; 74(2):149-54. PubMed ID: 8023779
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysis.
Ballantyne CM; Pazzucconi F; Pintó X; Reckless JP; Stein E; McKenney J; Bortolini M; Chiang YT
Clin Ther; 2001 Feb; 23(2):177-92. PubMed ID: 11293552
[TBL] [Abstract][Full Text] [Related]
17. Fluvastatin in severe hypercholesterolemia: analysis of a clinical trial database.
Peters TK
Am J Cardiol; 1995 Jul; 76(2):71A-75A. PubMed ID: 7604803
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of a combination fluvastatin-bezafibrate treatment for familial hypercholesterolemia: comparative analysis with a fluvastatin-cholestyramine combination.
Leitersdorf E; Muratti EN; Eliav O; Meiner V; Eisenberg S; Dann EJ; Sehayek E; Peters TK; Stein Y
Am J Med; 1994 May; 96(5):401-7. PubMed ID: 8192170
[TBL] [Abstract][Full Text] [Related]
19. Effects of statins on circulating oxidized low-density lipoprotein in patients with hypercholesterolemia.
Inami S; Okamatsu K; Takano M; Takagi G; Sakai S; Sano J; Mizuno K
Jpn Heart J; 2004 Nov; 45(6):969-75. PubMed ID: 15655272
[TBL] [Abstract][Full Text] [Related]
20. Lipid-lowering therapy with fluvastatin inhibits oxidative modification of low density lipoprotein and improves vascular endothelial function in hypercholesterolemic patients.
Inoue T; Hayashi M; Takayanagi K; Morooka S
Atherosclerosis; 2002 Feb; 160(2):369-76. PubMed ID: 11849660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
